The Catalyst Commitment
Article 1
The Origin Story — 03
2 min read

Why Catalyst Grows Slowly on Purpose — Peptide Company Built to Last

There was a faster way to grow. We chose the slower one on purpose.

Growth is easy if you’re willing to compromise.

You can raise prices and blame scarcity. You can lower quality and blame sourcing. You can make aggressive claims and let people draw their own conclusions. You can optimize for conversion and ignore retention. All of these are faster than the path we chose.

But fast growth with compromised trust isn’t growth. It’s borrowing from the future.

1
Direction our prices move: down
1
Metric that matters: retention

Catalyst measures success differently than most companies. We don’t measure it by how fast we grow. We measure it by whether people come back. We measure it by the quality of support we provide. We measure it by the time people spend reading the science instead of scrolling hype.

These metrics move slowly. They require patience. They require doing things that don’t scale—like actually reading customer feedback, actually understanding why people drop off, actually iterating on the experience instead of just the product.

Fast growth with compromised trust isn’t growth. It’s borrowing from the future.

We built Catalyst to last. That means we prioritize people who come back over people we can acquire once. It means we price for margin, not market share. It means we educate instead of oversell. These choices make us slower. They also make us more defensible. And they mean that people who trust us will stay with us.

One More Thing

We could have launched with influencer partnerships and aggressive paid acquisition. The economics would have worked in the short term. But every company that grows through paid attention has to keep paying to maintain it. We chose to grow through earned credibility — publishing test results, writing honest science content, and letting our customers be our advocates. Slower start. Stronger foundation.

GLP-3 RT

Ready to see the product?

GLP-3 RT is a triple-agonist research peptide targeting GLP-1, GIP, and Glucagon receptors.

Learn More Get GLP-3

The Catalyst Commitment

01
01
The Peptide Company We Wished Existed
02
02
How Catalyst Works — Education, Transparent Pricing, Real Peptide Science
03
03 You are here
Why Catalyst Grows Slowly on Purpose — Peptide Company Built to Last
04
04
Peptide Prices That Go Down, Not Up — Catalyst Pricing Commitment
Cart
Your cart is empty
$0
1
Add to your order
Bacteriostatic Water
30mL vial for reconstitution
$18